HIF1A and in situ carcinoma: In CIN and CIS of 283 samples, co-expression of HIF-1α was evaluated with c-Met (n = 186, 65.7%), CA9 (n = 181, 64.0%) and GLUT1 (n = 167, 59.0%), respectively.